MDI Biological Laboratory Hosts 2020 National Science Foundation Fellows

BAR HARBOR, ME, UNITED STATES - Aug 11, 2020 - BAR HARBOR, MAINE -- Six undergraduates from throughout the country studied at the MDI Biological Laboratory this summer under a Research Experiences for Undergraduates (REU) grant from the National Science Foundation (NSF) whose goal was to engage students "in meaningful ways" in ongoing research projects

Medicaid Transformation Project Releases Phase One Report

CHICAGO, IL, UNITED STATES - Aug 11, 2020 - Today, the Medicaid Transformation Project (MTP) announced the release of its Phase One Report, which summarizes the results of its first two years of work

CD Genomics Launches Complete Product Portfolio for Research to COVID-19 Response

SHIRLEY, NY, UNITED STATES - Aug 17, 2020 - CD Genomics is a genomics service company with good reputation in providing reliable microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services

CD Genomics Announces Advanced CDAMP® Panel Kits for SARS-CoV-2 Detection

SHIRLEY, NY, UNITED STATES - Aug 12, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced CDAMP® Panel Kits for SARS-CoV-2 detection

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

SHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Proteomics, an integrated CRO company committed to providing oncology multi-omics research services and personalized custom oncology research services, has recently launched its fully-developed gut metatranscriptome analysis solutions for the identification of key genes and gut physiology monitoring, as well as clinical diagnosis and screening for drug targets or for genes, enzymes and metabolites relevant for human health

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

SHIRLEY, NY, UNITED STATES - Aug 10, 2020 - Creative Enzymes, an excellent supplier and manufacturer located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possible

Kyruus Recruits Jamie Kiggen as its New Chief Financial Officer

BOSTON, MA, UNITED STATES - Aug 6, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Jamie Kiggen has joined its executive leadership team as Chief Financial Officer

Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite

CONNECTICUT, CT, UNITED STATES - Aug 6, 2020 - Phesi, a data-driven provider of clinical development analytics products and solutions, today announced a new country selection functionality has been added to ClinSite, its platform to provide investigator site intelligence to clients, enabling investigator site selection and management

Over 300 Clinical Studies Benefit from CluePoints COVID-19 Risk Management Support

KING OF PRUSSIA, PA - Aug 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials

Raremark® launches the Xperiome™ patient-powered knowledge platform to deliver new therapies faster and smarter

LONDON, UK - Aug 6, 2020 - Raremark®, the leading online patient community in rare disease, has today launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter

Panthera’s UK oncology clinical trial sites open for studies

PRESTON, UNITED KINGDOM - Aug 3, 2020 -  

• More than 1000 International Cancer Trials Suspended Due to COVID-19 

• Panthera working with the state of the art  Rutherford Cancer Centres across the UK  is open for clinical research activities including screening

Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin

CRAMLINGTON, UNITED KINGDOM - Jul 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, Inc

Abzena appoints Matthew LeClair as SVP and Site Head of San Diego Operations

SAN DIEGO, CA, UNITED KINGDOM - Aug 3, 2020 - Cambridge, UK and San Diego, CA, 3 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Matthew LeClair as Senior Vice President (SVP) and Site Head of its San Diego Operations

SkinCheck affordable skin cancer screening re-opens

CAMBRIDGE, UK - Aug 3, 2020 - Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, is reopening its SkinHealth SkinCheck clinics following enforced closure due to COVID-19

LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy

AMSTERDAM, THE NETHERLANDS - Aug 3, 2020 - LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development

Creative Peptides Provides Synthetic Peptides for Developing Vaccines

SHIRLEY, NY - Aug 3, 2020 - In the current COVID-19 pandemic, synthetic peptides play an important role in vaccine development. Creative Peptides, a supplier mainly engaged in the production of biologically active peptides, recently announced that it can provide synthetic peptides for vaccine development

Alfa Chemistry Materials—a New Option of Material Building Blocks

NY, NY - Aug 1, 2020 - Material building blocks are of vital importance in various areas such as in the production of semiconductors

Mitrefinch adds Facial Recognition to its Time and Attendance Solutions

NEWTON, MA - Jul 30, 2020 - Mitrefinch delivers biometric and cloud based  time and attendance solutions for midsize and large organizations including hospitals, medical facilities and senior care centers across North and South America

Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies

HOPKINTON, MA, UNITED STATES - Jul 29, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, and F-star Therapeutics, Limited (“F-star”), a privately-held clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announced that the companies have entered into a definitive share exchange agreement pursuant to which Spring Bank will, subject to stockholder approval, acquire all of the outstanding share capital of F-star in exchange for newly issued shares of Spring Bank in an all-stock transaction

Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer

IRVINE, CA - Jul 29, 2020 - Irvine, California, July 29, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the appointment of Brian Dow as Chief Financial Officer in the continued buildout of the Company’s leadership team